tiprankstipranks
Cordlife Group Limited (SG:P8A)
SGX:P8A

Cordlife Group (P8A) Share Price & Analysis

1 Followers

P8A Stock Chart & Stats

Day’s RangeS$0 - S$0
52-Week RangeS$0.13 - S$0.57
Previous CloseS$0.15
Volume10.00K
Average Volume (3M)424.46K
Market Cap
S$37.27M
Enterprise Value-S$25.41M
Total Cash (Recent Filing)S$65.17M
Total Debt (Recent Filing)S$2.22M
Price to Earnings (P/E)10.1
Beta0.52
May 10, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.01
Shares Outstanding256,307,744
10 Day Avg. Volume32,980
30 Day Avg. Volume424,462
Standard Deviation0.08
R-Squared0.03
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

2.01%0.00%0.06%97.93%
0.06% Other Institutional Investors
97.93% Public Companies and
Individual Investors

P8A FAQ

What was Cordlife Group Limited’s price range in the past 12 months?
Cordlife Group Limited lowest share price was S$0.13 and its highest was S$0.57 in the past 12 months.
    What is Cordlife Group Limited’s market cap?
    Currently, no data Available
    When is Cordlife Group Limited’s upcoming earnings report date?
    Cordlife Group Limited’s upcoming earnings report date is May 10, 2024 which is in 16 days.
      How were Cordlife Group Limited’s earnings last quarter?
      Cordlife Group Limited released its earnings results on Feb 29, 2024. The company reported S$0.006 earnings per share for the quarter, beating the consensus estimate of N/A by S$0.006.
        Is Cordlife Group Limited overvalued?
        According to Wall Street analysts Cordlife Group Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Cordlife Group Limited pay dividends?
          Cordlife Group Limited does not currently pay dividends.
          What is Cordlife Group Limited’s EPS estimate?
          Cordlife Group Limited’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Cordlife Group Limited have?
          Cordlife Group Limited has 267,525,360 shares outstanding.
            What happened to Cordlife Group Limited’s price movement after its last earnings report?
            Cordlife Group Limited reported an EPS of S$0.006 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -3.333%.
              Which hedge fund is a major shareholder of Cordlife Group Limited?
              Currently, no hedge funds are holding shares in SG:P8A
              ---

              Cordlife Group Stock Smart Score

              N/A
              Not Ranked
              1
              2
              3
              4
              5
              6
              7
              8
              9
              10

              Technicals

              SMA
              Negative
              20 days / 200 days
              Momentum
              -55.55%
              12-Months-Change

              Fundamentals

              Return on Equity
              2.73%
              Trailing 12-Months
              Asset Growth
              2.01%
              Trailing 12-Months

              Company Description

              Cordlife Group Limited

              Cordlife Group Ltd. is an investment holding company, which engages in the provision of cord blood banking services. It operates through the Banking and Diagnostics segments. The Banking segment comprises of cord blood, and cord lining and tissue services, which collects, processes and stores in laboratories. The Diagnostics segment consists of Metascreen, which is anon-invasive metabolic screening test designed for newborn babies, non-invasive prenatal testing and eyescreen, and a paediatric vision-screening services. The company was founded on May 2, 2001 and is headquartered in Singapore.
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              Oncolytics Biotech
              Precigen
              Vericel
              Verastem
              Cordlife Group
              Popular Stocks
              ---
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis